Govt plans to launch cheaper biosimilars for diabetes, cancerPost published:July 3, 2017Post category:Industry NewsThe plan to launch cheaper biosimilar drugs is in congruence with the govt’s affordable healthcare policy and makes India’s biotech industry globally competitive Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostTata Realty, StanChart PE JV buys Thane-Belapur land for Rs325 crore Next PostPharma firms yet to begin billing under new GST rates You Might Also Like Siemens introduces Simatic MV550 optical reader March 25, 2019 U.S. Navy Receives the Littoral Combat Ship 15 February 26, 2019 Taiwan’s Machine Tool Industry: An Inside Look November 28, 2017